2023-01-27 16:57:37 CINF Cincinnati Financial
01/27/23 01/2716:57 01/27/2316:57 | Cincinnati Financial announces preliminary Q4 pretax catastrophe losses of $141MCincinnati Financial announced that its consolidated fourth-quarter results are expected to include pretax catastrophe losses of approximately $141M, representing an impact on the fourth-quarter combined ratio of approximately 7.8 percentage points, based on estimated property casualty earned premiums. The company's five-year historical average contribution of catastrophe losses to the combined ratio is 3.9 percentage points for the fourth quarter. The catastrophe loss estimate includes $161M from Winter Storm Elliott, net of reinsurance and excluding any effects of reinstatement premiums assumed or ceded, in addition to less severe storms and favorable loss reserve development on previous catastrophe events, primarily ones that occurred in 2022. The estimate for total Q4 catastrophe losses incurred includes approximately $100M for the commercial lines insurance segment; $38M for the personal lines insurance segment; $2M for the excess and surplus lines insurance segment and $1M in total for Cincinnati Re and Cincinnati Global Underwriting Ltd. Estimated losses and expenses from catastrophe-related claims are expected to bring the company's fourth-quarter property casualty combined ratio to approximately 95%. The combined ratio before catastrophe losses for the quarter was approximately 2.5 percentage points better than that ratio for the first nine months of 2022 but continued to reflect increased uncertainty of estimated ultimate losses, due in part to elevated paid losses reflecting economic or other forms of inflation. Net written premium growth is estimated to be approximately 10% for the quarter. |
|
---|
Hot Stocks
|
Puma presents biomarker findings from Phase II study in HR+, TN breast cancer »
09:08 06/04/23 06/0409:08 06/04/2309:08
PBYI
Puma Biotechnology
Puma Biotechnology… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO »
08:48 06/04/23 06/0408:48 06/04/2308:48
AMGN
Amgen
Amgen announced the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Bristol-Myers presents follow-up results from Phase 3 CheckMate -9LA trial »
08:45 06/04/23 06/0408:45 06/04/2308:45
BMY
Bristol-Myers
Bristol-Myers Squibb… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ImmunoGen presents results Phase 3 confirmatory MIRASOL trial »
08:41 06/04/23 06/0408:41 06/04/2308:41
IMGN
ImmunoGen
ImmunoGen announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Summit presents data for investigational bispecific antibody ivonescimab »
08:28 06/04/23 06/0408:28 06/04/2308:28
SMMT
Summit Therapeutics
Summit Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
AstraZeneca says TAGRISSO achieved 'unprecedent' survival in EGFRm »
08:24 06/04/23 06/0408:24 06/04/2308:24
AZN
AstraZeneca
AstraZeneca says… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
G1 Therapeutics presents data from Phase 2 study of trilaciclib in TNBC »
07:28 06/04/23 06/0407:28 06/04/2307:28
GTHX
G1 Therapeutics
G1 Therapeutics presented… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Saudi Arabia, some OPEC members clash over production quotas, WSJ reports »
06:37 06/04/23 06/0406:37 06/04/2306:37
BP
BP
ConocoPhillips
Shell
TotalEnergies
Exxon Mobil
Chevron
Saudi Arabia and some… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Bank stocks too beaten down, JPMorgan among those to buy now, Barron's says »
06:29 06/04/23 06/0406:29 06/04/2306:29
JPM
JPMorgan
Citizens Financial
The past three months saw… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Ride not over for Eaton stock, Barron's says »
06:25 06/04/23 06/0406:25 06/04/2306:25
ETN
Eaton
A year ago, the backlog… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
IBM hiding in plain sight, paying big dividend, Barron's says »
06:21 06/04/23 06/0406:21 06/04/2306:21
IBM
IBM
IBM is one of the most… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Twitter loses another senior executive in charge of content, safety, WSJ says »
17:46 06/03/23 06/0317:46 06/03/2317:46
TWTR
A second senior executive… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen presents analysis of infections, parameters in Monumen-TAL1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune Group announces 3 trial-in-progress abstracts at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Additional Abstracts… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune Group (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents RP1 data from IGNYTE trial at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
| Healthcare Analysts hold… Story temporarily locked. |
Hot Stocks
|
Janssen announces results from Phase 1b RedirecTT-1 study »
17:18 06/03/23 06/0317:18 06/03/2317:18
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Evaxion's trial of EVX-01 met its primary endpoints of safety, tolerability »
17:09 06/03/23 06/0317:09 06/03/2317:09
EVAX
Evaxion Biotech
Evaxion Biotech presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell presents long-term follow up data from study evaluating GC012F »
17:07 06/03/23 06/0317:07 06/03/2317:07
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Sutro Biopharma announces results from Phase 1 dose-expansion study of luvelta »
17:02 06/03/23 06/0317:02 06/03/2317:02
STRO
Sutro Biopharma
Sutro Biopharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Equitrans Midstream's Mountain Valley Pipeline to proceed »
16:58 06/03/23 06/0316:58 06/03/2316:58
ETRN
Equitrans Midstream
On June 3, 2023, the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cogent Biosciences announces data from ongoing Phase 3 PEAK trial »
16:56 06/03/23 06/0316:56 06/03/2316:56
COGT
Cogent Biosciences
Cogent Biosciences… Story temporarily locked. ShowHide Related Items >><<
|